Tocilizumab linked with highest risk for neutropenia in comparison study that included abatacept, infliximab

Prensa/medios de comunicación

Período	21 abr. 2017

Cobertura de los medios

Nombre	Tocilizumab linked with highest risk for neutropenia in comparison study that included abatacept, infliximab
Nombre/canal del medio de comunicación	Healio
País/Territorio	Estados Unidos
Fecha	21/04/17
URL	www.healio.com/rheumatology/practice-management/news/online/%7bdda6be31-ef05-4caa-8b9b-71b36de336bd%7d/tocilizumab-linked-with-highest-risk-for-neutropenia-in-comparison-study-that-included-abatacept-infliximab
Personas	Francisco Espinoza